Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}

Blood. 2008 Nov 15;112(10):4250-8. doi: 10.1182/blood-2007-12-128967. Epub 2008 Jun 5.

Abstract

Neutrophils (polymorphonuclear leukocytes [PMNs]) are critical to the immune response, including clearance of infectious pathogens. Sepsis is associated with impaired PMN function, including chemotaxis. PMNs express peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a ligand-activated nuclear transcription factor involved in immune and inflammatory regulation. The role of PPAR-gamma in PMN responses, however, is not well characterized. We report that freshly isolated human PMNs constitutively express PPAR-gamma, which is up-regulated by the sepsis-induced cytokines TNF-alpha and IL-4. PMN chemotactic responses to formylmethionyl-leucyl-phenylalanine (fMLP) and IL-8 were dose-dependently inhibited by treatment with the PPAR-gamma ligands troglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and by transfection of PMN-like HL-60 cells with a constitutively active PPAR-gamma construct. Inhibition of chemotaxis by PPAR-gamma ligands correlated with decreases in extracellular signal-regulated kinase-1 and -2 activation, actin polymerization, and adherence to a fibrinogen substrate. Furthermore, PMN expression of PPAR-gamma was increased in sepsis patients and mice with either of 2 models of sepsis. Finally, treatment with the PPAR-gamma antagonist GW9662 significantly reversed the inhibition of PMN chemotaxis and increased peritoneal PMN recruitment in murine sepsis. This study indicates that PPAR-gamma activation is involved in PMN chemotactic responses in vitro and may play a role in the migration of these cells in vivo.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Actins / immunology
  • Anilides / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology
  • Cell Adhesion / drug effects
  • Cell Adhesion / immunology
  • Chemotaxis / drug effects
  • Chemotaxis / immunology*
  • Chromans / pharmacology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Fibrinogen / immunology
  • HL-60 Cells
  • Humans
  • Inflammation / immunology
  • Interleukin-4 / immunology
  • Interleukin-8 / immunology
  • Interleukin-8 / pharmacology
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 1 / immunology
  • Mitogen-Activated Protein Kinase 3 / immunology
  • N-Formylmethionine Leucyl-Phenylalanine / immunology
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • PPAR gamma / agonists
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / immunology*
  • Prostaglandin D2 / analogs & derivatives
  • Prostaglandin D2 / pharmacology
  • Sepsis / immunology*
  • Thiazolidinediones / pharmacology
  • Troglitazone
  • Tumor Necrosis Factor-alpha / immunology
  • Up-Regulation / drug effects
  • Up-Regulation / immunology*

Substances

  • 2-chloro-5-nitrobenzanilide
  • Actins
  • Anilides
  • Antineoplastic Agents
  • CXCL8 protein, human
  • Chromans
  • IL4 protein, human
  • Interleukin-8
  • PPAR gamma
  • Thiazolidinediones
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • N-Formylmethionine Leucyl-Phenylalanine
  • 9-deoxy-delta-9-prostaglandin D2
  • Fibrinogen
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Troglitazone
  • Prostaglandin D2